2022

• Hambley, T., Rae, I. (2022). Hans Charles Freeman 1929-2008. Historical Records of Australian Science, 33(2), 180-190. [More Information]

2021

• Lo, A., Bryce, N., Klein, A., Todd, M., Hambley, T. (2021). Novel polyamide amidine anthraquinone platinum(II) complexes: cytotoxicity, cellular accumulation, and fluorescence distributions in 2D and 3D cell culture models. Journal of Biological Inorganic Chemistry, 26, 217-233. [More Information]
• Lo, A., Chen, J., Murray, V., Todd, M., Hambley, T. (2021). Platinum binding preferences dominate the binding of novel polyamide amidine anthraquinone platinum(ii) complexes to DNA. Dalton Transactions, 50(48), 17945-17952. [More Information]
• Glenister, A., Chen, C., Paterson, D., Renfrew, A., Simone, M., Hambley, T. (2021). Warburg Effect Targeting Co(III) Cytotoxin Chaperone Complexes. Journal of Medicinal Chemistry, 64(5), 2678-2690. [More Information]

2020

• Hawkett, B., Bryce, N., Jain, N., Hambley, T., Pham, B. (2020). Method of Treating Cancer. Patent No. 10376589, 10376589, 2012245080, 2699233, 2833413, 6038881, 616780, TR201312152, 2012245080, 2699233, 6038881, 616780, TR201312152. , , Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, New Zealand, Portugal, Spain, Switzerland, Turkey, United Kingdom, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, New Zealand, Portugal, Spain, Switzerland, Turkey, United Kingdom.
• Chen, C., Gui, X., Kappen, P., Renfrew, A., Hambley, T. (2020). The effect of charge on the uptake and resistance to reduction of platinum(IV) complexes in human serum and whole blood models. Metallomics, 12(10), 1599-1615. [More Information]
• Chen, C., Kappen, P., Gibson, D., Hambley, T. (2020). trans-Platinum(iv) pro-drugs that exhibit unusual resistance to reduction by endogenous reductants and blood serum but are rapidly activated inside cells:1H NMR and XANES spectroscopy study. Dalton Transactions, 49(23), 7722-7736. [More Information]
• Gretarsdottir, J., Jonsdottir, S., Lewis, W., Hambley, T., Suman, S. (2020). Water-Soluble alpha‑Amino Acid Complexes of Molybdenum as Potential Antidotes for Cyanide Poisoning: Synthesis and Catalytic Studies of Threonine, Methionine, Serine, and Leucine Complexes. Inorganic Chemistry, 59(24), 18190-18204. [More Information]

2019

• Glenister, A., Simone, M., Hambley, T. (2019). A Warburg effect targeting vector designed to increase the uptake of compounds by cancer cells demonstrates glucose and hypoxia dependent uptake. PloS One, 14(7), 1-16. [More Information]
• Hambley, T. (2019). Element 78 - Platinum. Australian Journal of Chemistry, 72(9), 649-651. [More Information]
• Di Marco, L., Zhang, J., Doan, J., Kim, B., Yamamoto, N., Bryce, N., Hambley, T. (2019). Modulating the cellular uptake of fluorescently tagged substrates of prostate-specific antigen before and after enzymatic activation. Bioconjugate Chemistry, 30(1), 124-133. [More Information]
• Chen, C., Hambley, T. (2019). The impact of highly electron withdrawing carboxylato ligands on the stability and activity of platinum(IV) pro-drugs. Inorganica Chimica Acta, 494, 84-90. [More Information]
• Chen, C., Kappen, P., Hambley, T. (2019). The reduction of cis-platinum(IV) complexes by ascorbate and in whole human blood models using 1H NMR and SANES spectroscopy. Metallomics, 11(3), 686-695. [More Information]
• Hambley, T. (2019). Transporter and protease mediated delivery of platinum complexes for precision oncology. Journal of Biological Inorganic Chemistry, 24(4), 457-466. [More Information]

2018

• Kolanowski, J., Dawson, L., Mitchell, L., Lim, Z., Graziotto, M., Filipek, W., Hambley, T., New, E. (2018). A fluorescent probe for investigating metabolic stability of active transplatin analogues. Sensors and Actuators B: Chemical, 255(Part 3), 2721-2724. [More Information]
• Carney, I., Kolanowski, J., Lim, Z., Chekroun, B., Torrisi, A., Hambley, T., New, E. (2018). A ratiometric iron probe enables investigation of iron distribution within tumour spheroids. Metallomics, 10(4), 553-556. [More Information]
• Renfrew, A., O'Neill, E., Hambley, T., New, E. (2018). Harnessing the properties of cobalt coordination complexes for biological application. Coordination Chemistry Reviews, 375, 221-233. [More Information]

2017

• Akerfeldt, M., Tran, C., Shen, C., Hambley, T., New, E. (2017). Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells. Journal of Biological Inorganic Chemistry, 22(5), 765-774. [More Information]
• Glenister, A., Chen, C., Tondl, E., Paterson, D., Hambley, T., Renfrew, A. (2017). Targeting curcumin to specific tumour cell environments: the influence of ancillary ligands. Metallomics, 9(6), 699-705. [More Information]
• Green, B., Renfrew, A., Glenister, A., Turner, P., Hambley, T. (2017). The influence of the ancillary ligand on the potential of cobalt(III) complexes to act as chaperones for hydroxamic acid-based drugs. Dalton Transactions, 46(45), 15897-15907. [More Information]
• Graziotto, M., Akerfeldt, M., Gunn, A., Yang, K., Somerville, M., Coleman, N., Roberts, B., Hambley, T., New, E. (2017). The influence of the ethane-1,2-diamine ligand on the activity of a monofunctional platinum complex. Journal of Inorganic Biochemistry, 177, 328-334. [More Information]

2016

• Puranik, R., Bao, B., Bonin, A., Kaur, R., Weder, J., Casbolt, L., Hambley, T., Lay, P., Barter, P., Rye, K. (2016). A novel class of copper(II)- and zinc(II)-bound non-steroidal anti-inflammatory drugs that inhibits acute inflammation in vivo. Cell and Bioscience, 6(1), 1-7. [More Information]
• Shen, C., Kolanowski, J., Tran, C., Kaur, A., Akerfeldt, M., Rahme, M., Hambley, T., New, E. (2016). A ratiometric fluorescent sensor for the mitochondrial copper pool. Metallomics, 8(9), 915-919. [More Information]

2015

• Renfrew, A., Bryce, N., Hambley, T. (2015). Cobalt(III) chaperone complexes of curcumin: Photoreduction, cellular accumulation and light-selective toxicity towards tumour cells. Chemistry - A European Journal, 21(43), 15224-15234. [More Information]
• Shen, C., Harris, B., Dawson, L., Charles (nee Slaviero), K., Hambley, T., New, E. (2015). Fluorescent sensing of monofunctional platinum species. Chemical Communications, 51(29), 6312-6314. [More Information]
• Roberts, M., Pham, T., Doan, J., Jiang, C., Hambley, T., Greguric, I., Fraser, B. (2015). Radiosynthesis and 'click' conjugation of ethynyl-4-[18F]fluorobenze - an improved [18F]synthon for indirect radiolabeling. Journal of Labelled Compounds and Radiopharmaceuticals, 58(13-14), 473-478. [More Information]

2014

• Eljack, N., Ma, H., Drucker, J., Shen, C., Hambley, T., New, E., Friedrich, T., Clarke, R. (2014). Mechanisms of cell uptake and toxicity of the anticancer drug cisplatin. Metallomics, 6(11), 2126-2133. [More Information]
• Klein, A., Hambley, T. (2014). Platinum-Based Anticancer Agents. In Tim Storr (Eds.), Ligand Design in Medicinal Inorganic Chemistry, (pp. 9-45). Chichester, United Kingdom: John Wiley & Sons. [More Information]

2013

• Renfrew, A., Bryce, N., Hambley, T. (2013). Delivery and release of curcumin by a hypoxia-activated cobalt chaperone: a XANES and FLIM study. Chemical Science, 4(9), 3731-3739. [More Information]
• Zhang, J., Bonnitcha, P., Wexselblatt, E., Klein, A., Najajreh, Y., Gibson, D., Hambley, T. (2013). Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design. Chemistry - A European Journal, 19(5), 1672-1676. [More Information]
• Chen, C., Zhang, J., Aitken, J., Hambley, T. (2013). Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells. Journal of Medicinal Chemistry, 56(21), 8757-8764. [More Information]
• Roberts, M., Pham, T., Doan, J., Fraser, B., Hambley, T., Greguric, I. (2013). Radiosynthesis of [18F]-ethynyl-4-fluorobenzene for click conjugation. Journal of Labelled Compounds and Radiopharmaceuticals, 56(S1), P091-P091.
• Bryce, N., Pham, B., Fong, N., Jain, N., Pan, E., Whan, R., Hambley, T., Hawkett, B. (2013). The composition and end-group functionality of sterically stabilized nanoparticles enhances the effectiveness of co-administered cytotoxins. Biomaterials Science, 1(12), 1260-1272. [More Information]

2012

• Hawkett, B., Hambley, T., Bryce, N., Pham, B., Jain, N. (2012). A method for the treatment of a solid tumour. Patent No. CA2833413 A1, CA2833413 A1, WO2012142669 A1. , Canada, Canada.
• Bonnitcha, P., Kim, B., Hocking, R., Clegg, J., Turner, P., Neville, S., Hambley, T. (2012). Cobalt complexes with tripodal ligands: Implications for the design of drug chaperones. Dalton Transactions, 41(37), 11293-11304. [More Information]
• Yamamoto, N., Renfrew, A., Kim, B., Bryce, N., Hambley, T. (2012). Dual Targeting of Hypoxic and Acidic Tumor Environments with a Cobalt(III) Chaperone Complex. Journal of Medicinal Chemistry, 55(24), 11013-11021. [More Information]
• Yamamoto, N., Bryce, N., Metzler-Nolte, N., Hambley, T. (2012). Effects of enzymatic activation on the distribution of fluorescently tagged MMP-2 cleavable peptides in cancer cells and spheroids. Bioconjugate Chemistry, 23(6), 1110-1118. [More Information]
• Zhang, J., Bryce, N., Lanzirotti, A., Chen, C., Paterson, D., De Jonge, M., Howard, D., Hambley, T. (2012). Getting to the core of platinum drug bio-distributions: the penetration of anti-cancer platinum complexes into spheroid tumour models. Metallomics, 4(11), 1209-1217. [More Information]
• Lay, P., Hambley, T. (2012). Hans C. Freeman preface. Journal of Inorganic Biochemistry, 115, 113-113. [More Information]
• Zhang, J., Wexselblatt, E., Hambley, T., Gibson, D. (2012). Pt(IV) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate. Chemical Communications, 48(6), 847-849. [More Information]
• Hall, M., Daly, H., Zhang, J., Zhang, M., Alderden, R., Pursche, D., Foran, G., Hambley, T. (2012). Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES). Metallomics, 4(6), 568-575. [More Information]
• Failes, T., Battle, A., Chen, C., Cullinane, C., Woods, R., Elliott, R., Deacon, G., Hambley, T. (2012). Structural and anticancer properties of hydrogen bonded diphenyl phosphate adducts of Pt(IV) complexes: The importance of pKa matching. Journal of Inorganic Biochemistry, 115, 220-225. [More Information]
• Guo, S., Mason, D., Turland, S., Lawrenz, E., Kelly, L., Fallon, G., Gatehouse, B., Bond, A., Deacon, G., Battle, A., Hambley, T., et al (2012). Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl]. Journal of Inorganic Biochemistry, 115(2012), 226-239. [More Information]
• Zhang, J., Bryce, N., Siegele, R., Carter, E., Paterson, D., De Jonge, M., Howard, D., Ryan, C., Hambley, T. (2012). The use of spectroscopic imaging and mapping techniques in the characterisation and study of DLD-1 cell spheroid tumour models. Integrative Biology, 4(9), 1072-1080. [More Information]

2011

• Wolf, S., Huynh, T., Bryce, N., Hambley, T., Wakelin, L., Stewart, B., Catchpoole, D. (2011). Intracellular trafficking as a determinant of AS-DACA cytotoxicity in rhabdomyosarcoma cells. BMC Cell Biology, 12(36), 1-11. [More Information]
• Yadav, P., Beveridge, R., Blay, J., Boyd, A., Chojnacka, M., Decken, A., Deshpande, A., Gardiner, M., Hambley, T., Hughes, M., New, E., et al (2011). Platinum-oxazoline complexes as anti-cancer agents: syntheses, characterisation and initial biological studies. MedChemComm (Medicinal Chemistry Communications), 2(4), 274-277. [More Information]
• Daly, H., Hall, M., Failes, T., Zhang, M., Foran, G., Hambley, T. (2011). Stabilization of Triam(m)inechloridoplatinum Complexes by Oxidation to Pt(IV). Australian Journal of Chemistry, 64(3), 273-278. [More Information]
• Norman, J., Hambley, T. (2011). Targeting strategies for metal-based therapeutics. In Professor Enzo Alessio (Eds.), Bioinorganic Medicinal Chemistry, (pp. 49-78). Germany: Wiley - V C H Verlag GmbH & Co. KGaA. [More Information]
• Cubo, L., Hambley, T., Sanz Miguel, P., Carnero, A., Navarro-Ranninger, C., Quiroga, A. (2011). The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity. Dalton Transactions, 40(2), 344-347. [More Information]
• Kim, B., Hambley, T., Bryce, N. (2011). Visualising the hypoxia selectivity of cobalt(III) prodrugs. Chemical Science, 2(11), 2135-2142. [More Information]

2010

• Ma, Y., Bryce, N., Whan, R., Xiao, L., Li, K., Ruys, A., Hambley, T., Boughton, P. (2010). Growth of DLD-1 Colon Cancer Cells on VariotisTM Scaffolds of Controlled Porosity: A Preliminary Study. Journal of Biomimetics, Biomaterials, and Tissue Engineering, 8, 79-89. [More Information]
• Bonin, A., Yanez, J., Fukuda, C., Teng, X., Dillon, C., Hambley, T., Lay, P., Davies, N. (2010). Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper-indomethacin in rats. Cancer Chemotherapy and Pharmacology, 66(4), 755-764. [More Information]
• Battle, A., Bond, A., Chow, A., Daniels, D., Deacon, G., Hambley, T., Junk, P., Mason, D., Wang, J. (2010). Syntheses and structures of N-polyfluorophenyl- and N,N'-bis(polyfluorophenyl)ethane-1,2-diaminato(1- or 2-)platinum(II) complexes. Journal of Fluorine Chemistry, 131(11), 1229-1236. [More Information]

2009

• Bryce, N., Zhang, J., Whan, R., Yamamoto, N., Hambley, T. (2009). Accumulation of an anthraquinone and its platinum complexes in cancer cell spheroids: The effect of charge on drug distribution in solid tumour models. Chemical Communications, 2009 (19), 2673-2675. [More Information]
• Whan, R., Messerle, B., Hambley, T. (2009). Binding of [Pt(1C3)(dien)]2+ to the duplex DNA oligonucleotide 5'-d(TGGCCA)-3': The effect of an appended positive charge on the orientation and location of anthraquinone intercalation. Dalton Transactions, 2009 (6), 932-939. [More Information]
• Er, H., Hambley, T. (2009). Enantioselectivity and stereoselectivity in the reactions of the enantiomers of the platinum complex [PtCl(2)(ahaz)] (ahaz = 3(R)- or 3(S)-aminohexahydroazepine) with DNA. Journal of Inorganic Biochemistry, 103(2), 168-173. [More Information]
• New, E., Roche, C., Madawala, R., Zhang, J., Hambley, T. (2009). Fluorescent analogues of quinoline reveal amine ligand loss from cis and trans platinum(II) complexes in cancer cells. Journal of Inorganic Biochemistry, 103(8), 1120-1125. [More Information]
• Diakos, C., Messerle, B., Murdoch, P., Parkinson, J., Sadler, P., Fenton, R., Hambley, T. (2009). Identification by NMR spectroscopy of the two steroisomers of the platinum complex [PtCl2(S-ahaz)] (S-ahaz = 3(S)-aminohexahydroazepine) bound to a DNA 14-mer oligonucleotide. NMR evidence of structural alteration of a platinated A.T-rich 14-mer DNA duplex. Inorganic Chemistry, 48(7), 3047-3056. [More Information]
• Hambley, T. (2009). Improving anticancer drug penetration in solid tumours (Invited lecture). 14th International Conference on Biological Inorganic Chemistry, N/A: N/A.
• Hambley, T., Gui, X. (2009). Investigations into the electrochemical properties of Pt(IV) agents. 14th International Conference on Bioinorganic Chemistry.
• New, E., Duan, R., Zhang, J., Hambley, T. (2009). Investigations using fluorescent ligands to monitor platinum(IV) reduction and platinum(II) reactions in cancer cells. Dalton Transactions, 2009 (16), 3092-3101. [More Information]
• Clarke, A., Yamamoto, N., Jensen, P., Hambley, T. (2009). Iron(III) complexes of fluorescent hydroxamate ligands: preparation, properties, and cellular processing. Dalton Transactions, 2009 (48), 10787-10798. [More Information]
• Hambley, T. (2009). Is anticancer drug development heading in the right direction? Cancer Research, 69(4), 1259-1262. [More Information]
• Comba, P., Hambley, T., Martin, B. (2009). Molecular Modeling of Inorganic Compounds: Third, Completely Revised and Enlarged Edition. Federal Republic of Germany: Wiley - V C H Verlag GmbH & Co. KGaA.
• Zhang, J., Whan, R., Hambley, T. (2009). Platinum anticancer drugs, chemical biology of. In Natanya Civjan (Eds.), Wiley Encyclopaedia of Chemical Biology, (pp. 721-730). Hoboken, New Jersey, USA: John Wiley & Sons.
• Klein, A., Hambley, T. (2009). Platinum drug distribution in cancer cells and tumors. Chemical Reviews, 109(10), 4911-4920. [More Information]
• Diakos, C., Zhang, M., Beale, P., Fenton, R., Hambley, T. (2009). Synthesis, characterisation and in vitro cytotoxicity studies of a series of chiral platinum(II) complexes based on the 2-aminomethylpyrrolidine ligand: X-ray crystal structure of [PtC12(R-dimepyrr)] (R-dimepyrr = N-dimethyl-2(R)-aminomethylpyrrolidine). European Journal of Medicinal Chemistry, 44(7), 2807-2814. [More Information]
• Hambley, T. (2009). Targeted cancer therapeutics response. Cancer Research, 69(4), 1267-1267.
• Zhang, J., Bryce, N., Hambley, T. (2009). The penetration and accumulation of anti-tumour platinum(II) complexes in spheroid tumour models. 14th International Conference on Biological Inorganic Chemistry, N/A: N/A.
• Bryce, N., Zhang, J., Hambley, T. (2009). Visualising drug diffusion in a 3-dimensional tumour spheroid model system. 100th Annual Meeting of the American Association for Cancer Research, USA: N/A.
• Yamamoto, N., Bryce, N., Danos, S., Hambley, T. (2009). Visualising the uptake of fluorescently tagged cobalt chaperones in solid tumour models. 14th International Conference on Biological Inorganic Chemistry, N/A: N/A.

2008

• Davies, M., Hall, M., Berners-Price, S., Hambley, T. (2008). [(1)H, (15)N] Heteronuclear Single Quantum Coherence NMR Study of the Mechanism of Aquation of Platinum(IV) Ammine Complexes. Inorganic Chemistry, 47(17), 7673-7680. [More Information]
• Yamamoto, N., Danos, S., Bonnitcha, P., Failes, T., New, E., Hambley, T. (2008). Cellular uptake and distribution of cobalt complexes of fluorescent ligands. Journal of Biological Inorganic Chemistry, 13(6), 861-871. [More Information]
• Hambley, T. (2008). Physiological Targeting to Improve Anticancer Drug Selectivity. Australian Journal of Chemistry, 61(9), 647-653. [More Information]
• Guenther, K., Hambley, T., Kassiou, M. (2008). Radiolabelled probes for imaging multidrug resistance using single photon emission tomography (SPECT) and positron emission tomography (PET). In Nicola Antonio Colabufo (Eds.), Multidrug Resistance: Biological and Pharmaceutical Advances in Antitumour Treatment, (pp. 291-320). India: Research Signpost.

2007

• Hall, M., Mellor, H., Callaghan, R., Hambley, T. (2007). Basis for design and development of platinum(IV) anticancer complexes. Journal of Medicinal Chemistry, 50(15), 3403-3411. [More Information]
• Hall, M., Failes, T., Yamamoto, N., Hambley, T. (2007). Bioreductive activation and drug chaperoning in cobalt pharmaceuticals. Dalton Transactions, (36), 3983-3990. [More Information]
• Hocking, R., Hambley, T. (2007). Database analysis of transition metal carbonyl bond lengths: Insight into the periodicity of pi back-bonding, sigma donation, and the factors affecting the electronic structure of the TM-C=O moiety. Organometallics, 26(11), 2815-2823. [More Information]
• Hambley, T. (2007). Developing new metal-based therapeutics: Challenges and opportunities. Dalton Transactions, 2007 (43), 4929-4937. [More Information]
• Hocking, R., Deeth, R., Hambley, T. (2007). DFT study of the systematic variations in metal-ligand bond lengths of coordination complexes: The crucial role of the condensed phase. Inorganic Chemistry, 46(20), 8238-8244. [More Information]
• Alderden, R., Mellor, H., Modok, S., Hall, M., Sutton, S., Newville, M., Callaghan, R., Hambley, T. (2007). Elemental tomography of cancer-cell spheroids reveals incomplete uptake of both platinum(II) and platinum(IV) complexes. Journal of the American Chemical Society, 129(44), 13400-13401. [More Information]
• Hambley, T. (2007). Metal-based therapeutics. Science, 318(5855), 1392-1393. [More Information]
• Failes, T., Cullinane, C., Diakos, C., Yamamoto, N., Lyons, J., Hambley, T. (2007). Studies of a Cobalt(III) complex of the MMP inhibitor marimastat: A potential hypoxia-activated prodrug. Chemistry - A European Journal, 13(10), 2974-2982. [More Information]
• Failes, T., Hambley, T. (2007). Towards bioreductively activated prodrugs: Fe(III) complexes of hydroxamic acids and the MMP inhibitor marimastat. Journal of Inorganic Biochemistry, 101(0), 396-403. [More Information]
• Modok, S., Scott, R., Alderden, R., Hall, M., Mellor, H., Bohic, S., Roose, T., Hambley, T., Callaghan, R. (2007). Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model. British Journal of Cancer, 97(2), 194-200. [More Information]
• Hall, M., Underwood, C., Failes, T., Foran, G., Hambley, T. (2007). Using XANES to monitor the oxidation state of cobalt complexes. Australian Journal of Chemistry, 60(3), 180-183. [More Information]

2006

• Alderden, R., Mellor, H., Modok, S., Hambley, T., Callaghan, R. (2006). Cytotoxic efficacy of an anthraquinone linked platinum anticancer drug. Biochemical Pharmacology, 71(8), 1136-1145. [More Information]
• Diakos, C., Fenton, R., Hambley, T. (2006). DNA-binding and molecular mechanics modelling studies of the bulky chiral platinum(II) complex [PtCl2(mepyrr)] (mepyrr = N-methyl-2-aminomethylpyrrolidine). Journal of Inorganic Biochemistry, 100(12), 1965-1973. [More Information]
• Costa, L., Hambley, T., Rocha, W., De Almeida, W., Dos Santos, H. (2006). Kinetics and structural aspects of the cisplatin interactions with guanine: A quantum mechanical description. International Journal of Quantum Chemistry, 106(9), 2129-2144. [More Information]
• Failes, T., Hambley, T. (2006). Models of hypoxia activated prodrugs: Co(III) complexes of hydroxamic acids. Dalton Transactions, 2006 (15), 1895-1901. [More Information]
• Battle, A., Choi, R., Hibbs, D., Hambley, T. (2006). Platinum(IV) analogues of AMD473 (cis-[PtCl2(NH3)(2-picoline)]): preparative, structural, and electrochemical studies. Inorganic Chemistry, 45(16), 6317-6322. [More Information]
• Alderden, R., Hall, M., Hambley, T. (2006). The discovery and development of cisplatin. Journal of Chemical Education, 83(5), 728-734.
• Hall, M., Alderden, R., Zhang, M., Beale, P., Cai, Z., Lai, B., Stampfl, A., Hambley, T. (2006). The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours. Journal of Structural Biology, 155(1), 38-44. [More Information]
• Bonnitcha, P., Hall, M., Underwood, C., Foran, G., Zhang, M., Beale, P., Hambley, T. (2006). XANES investigation of the Co oxidation state in solution and in cancer cells treated with Co(III) complexes. Journal of Inorganic Biochemistry, 100(5-6), 963-971. [More Information]

2005

• Malina, J., Voitiskova, M., Brabec, V., Diakos, C., Hambley, T. (2005). DNA adducts of the enantiomers of the Pt(II) complexes of the ahaz ligand (ahaz=3-aminohexahydroazepine) and recognition of these adducts by HMG domain proteins. Biochemical and Biophysical Research Communications, 332(4), 1034-1041. [More Information]
• Ramadan, S., Bonin, A., Kennedy, B., Hambley, T., Lay, P. (2005). Nuclear magnetic resonance analysis of indomethacin-induced gastric ulcers. Chemical Research in Toxicology, 18(2), 123-128. [More Information]
• Hocking, R., Hambley, T. (2005). Structural measures of element-oxygen bond covalency from the changes to the delocalisation of the carboxylate ligand. Dalton Transactions, 2005 (5), 969-978. [More Information]
• Mellor, H., Hall, M., Hambley, T., Snelling, S., Modok, S., Jaffar, M., Callaghan, R. (2005). The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes. Biochemical Pharmacology, 70(8), 1137-1146. [More Information]

2004

• Hall, M., Martin, C., Ferguson, D., Phillips, R., Hambley, T., Callaghan, R. (2004). Comparative Efficacy Of Novel Platinum(IV) Compounds With Established Chemotherapeutic Drugs In Solid Tumour Models. Biochemical Pharmacology, 67(1), 17-30. [More Information]
• Dillon, C., Hambley, T., Kennedy, B., Lay, P., Weder, J., Zhou, Q. (2004). Copper And Zinc Complexes As Antiinflammatory Drugs. In Astrid Sigel & Helmut Sigel (Eds.), Metal Ions in Biological Systems : Volume 41 : Metal Ions and their Complexes in Medication, (pp. 253-277). New York: Marcel Dekker.
• Ramadan, S., Hambley, T., Kennedy, B., Lay, P. (2004). Nmr Spectroscopic Characterization Of Copper(Ii) And Zinc(Ii) Complexes Of Indomethacin. Inorganic Chemistry, 43(9), 2943-2946. [More Information]
• Rendina, L., Hambley, T. (2004). Platinum. In D. E. Fenton (Eds.), Comprehensive Coordination Chemistry II : From biology to nanotechnology. Volume 6: Transition Metal groups 9-12, (pp. 673-745). Amsterdam: Elsevier. [More Information]
• Hall, M., Dolman, R., Hambley, T. (2004). Platinum(Iv) Anticancer Complexes. In Astrid Sigel & Helmut Sigel (Eds.), Metal Ions in Biological Systems: Volume 42. Metal Complexes in Tumor Diagnosis and as Anticancer Agents, (pp. 297-322). New York: Marcel Dekker.
• Allan, R., Greenwood, J., Hambley, T., Hanrahan, J., Hibbs, D., Itani, S., Tran, H., Turner, P. (2004). Studies On Pyridazine Azide Cyclisation Reactions. Organic and Biomolecular Chemistry, 2(12), 1782-8-1788. [More Information]
• Hall, M., Amjadi, S., Zhang, M., Beale, P., Hambley, T. (2004). The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines. Journal of Inorganic Biochemistry, 98, 1614-1624. [More Information]
• Levina, A., Codd, R., Foran, G., Hambley, T., Maschmeyer, T., Masters, A., Lay, P. (2004). X-Ray Absorption Spectroscopic Studies Of Chromium(V/Iv/Iii)2-Ethyl-2-Hydroxybutanoato(2-/1-) Complexes. Inorganic Chemistry, 43(3), 1046-1055. [More Information]

2003

• Failes, T., Diakos, C., Underwood, C., Hambley, T., Cullinane, C., Lyons, J. (2003). Can metal complexes serve as hypoxia activated prodrugs? Investigations of a Co(III) complex of the MMP inhibitor marimastat. Journal of Inorganic Biochemistry, 96(1), 128.
• Field, L., Messerle, B., Rehr, M., Soler, L., Hambley, T. (2003). Cationic iridium(I) complexes as catalysts for the alcoholysis of silanes. Organometallics, 22(12), 2387-2395. [More Information]
• Hall, M., Hambley, T., Beale, P., Zhang, M., Dillon, C., Foran, G., Stampfl, A., Lai, B. (2003). Does platinum(IV) survive in tumour cells? Journal of Inorganic Biochemistry, 96(1), 141.
• Waller, M., Hibbs, D., Overgaard, J., Hanrahan, J., Hambley, T. (2003). Flavone. Acta Crystallographica. Section E: Structure Reports Online, 59(6), o767-o768. [More Information]
• Dillon, C., Hambley, T., Kennedy, B., Lay, P., Zhou, Q., Davies, N., Biffen, R., Regtop, H. (2003). Gastrointestinal Toxicity, Antiinflammatory Activity, and Superoxide Dismutase Activity of Copper and Zinc Complexes of the Antiinflammatory Drug Indomethacin. Chemical Research in Toxicology, 16(1), 28-37. [More Information]
• Alderden, R., Hall, M., Amjadi, S., Hambley, T., Beale, P., Zhang, M., Lai, M., Stampfl, A. (2003). Increasing the cellular accumulation of platinum(IV) complexes. Journal of Inorganic Biochemistry, 96(1), 89.
• Failes, T., Hambley, T. (2003). Insights into Pt(II)-hydroxamate bonding through the crystal structures of DMSO complexes. Australian Journal of Chemistry, 56(1), 45-48. [More Information]
• Bulluss, G., Waller, M., Hambley, T. (2003). Investigation of rotamers about the Pt-N7 bonds in bulky [Pt(d(GpG))(diamine)] complexes. Journal of Inorganic Biochemistry, 96(1), 108.
• Munk, V., Diakos, C., Ellis, L., Fenton, R., Hambley, T., Messerle, B. (2003). Investigations into the interactions between DNA and conformationally constrained pyridylamineplatinum(II) analogues of AMD473. Inorganic Chemistry, 42(11), 3582-3590. [More Information]
• Bernhardt, P., Hambley, T., Lawrance, G., Maeder, M., Wilkes, E. (2003). Isomers of 1,4,8,11-tetraazacyclotetradecane-6,13-dicarboxylate characterized as cobalt(III) complexes. Australian Journal of Chemistry, 56(7), 679-684. [More Information]
• Bulluss, G., Waller, M., Hambley, T. (2003). Mechanism of action of platinum complex binding to DNA. Journal of Inorganic Biochemistry, 96(1), 109.
• Brown, K., Geue, R., Hambley, T., Hockless, D., Rae, A., Sargeson, A. (2003). Specificity in template syntheses of hexaaza-macrobicyclic cages: [Pt(Me5-tricosatrieneN6)]4+ and [Pt(Me5-tricosaneN6)]4+. Organic and Biomolecular Chemistry, 1, 1598-1608. [More Information]
• Hocking, R., Hambley, T. (2003). Structural insights into transition-metal carbonyl bonding. Chemical Communications, 2003 (13), 1516-1517. [More Information]
• Hocking, R., Hambley, T. (2003). Structural measure of metal-ligand covalency from the bonding in carboxylate ligands. Inorganic Chemistry, 42(9), 2833-2835. [More Information]
• Hall, M., Dillon, C., Zhang, M., Beale, P., Cai, Z., Lai, B., Stampfl, A., Hambley, T. (2003). The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells. Journal of Biological Inorganic Chemistry, 8(7), 726-732. [More Information]
• Hibbs, D., Overgaard, J., Hambley, T., Gatti, C. (2003). The electron density in flavones I. Baicalein. New Journal of Chemistry, 27(9), 1392-1398. [More Information]
• Failes, T., Hall, M., Hambley, T. (2003). The first examples of platinum amine hydroxamate complexes: structures and biological activity. Dalton Transactions, 2003 (8), 1596-1600. [More Information]
• Underwood, C., Min, D., Lyons, J., Hambley, T. (2003). The interaction of metal ions and Marimastat with matrix metalloproteinase 9. Journal of Inorganic Biochemistry, 95(2-3), 165-170. [More Information]
• Ellis, L., Perkins, D., Turner, P., Hambley, T. (2003). The preparation and charcterisation of cyclam/anthraquinone macrocyle/intercalator complexes and their interactions with DNA. Dalton Transactions, 2003 (13), 2728-2736. [More Information]
• Giannikopoulos, G., Teo, C., Hall, M., Fenton, R., Hambley, T. (2003). The synthesis and in vitro cytotoxicity of two trans-platinum complexes of heterocyclic amines. Australian Journal of Chemistry, 56(7), 685-689. [More Information]
• Zhou, Q., Hambley, T., Kennedy, B., Lay, P. (2003). XAFS studies of anti-inflammatory dinuclear and mononuclear Zn(II) complexes of indomethacin. Inorganic Chemistry, 42(25), 8557-8566. [More Information]
• Hall, M., Foran, G., Zhang, M., Beale, P., Hambley, T. (2003). XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents. Journal of the American Chemical Society, 125(25), 7524-7525. [More Information]

2002

• Hotze, A., Chen, Y., Hambley, T., Parsons, S., Kratochwil, N., Parkinson, J., Munk, V., Sadler, P. (2002). Cis-[PtCl2(NH3){2-(2-hydroxyethyl)pyridine}] - an Analogue of the Anticancer Drug AMD473: Unusual Hydrolysis Rates and pKa Values for the Diaqua Adduct. European Journal of Inorganic Chemistry, 2002 (5), 1035-1039.
• Weder, J., Dillon, C., Hambley, T., Kennedy, B., Lay, P., Biffin, J., Regtop, H., Davies, N. (2002). Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized. Coordination Chemistry Reviews, 232(1-2), 95-126. [More Information]
• Battle, A., Deacon, G., Dolman, R., Hambley, T. (2002). Electrochemistry, Protein Binding and Crystal Structures of Platinum(II) and Platinum(IV) Carboxylato Complexes. Australian Journal of Chemistry, 55(11), 699-704. [More Information]
• Davies, M., Wong, P., Battle, A., Haddad, G., McKeage, M., Hambley, T. (2002). Examination of the effects of oxidation and ring closure on the cytotoxicities of the platinum complexes of N-(2-hydroxyethyl)ethane-1,2-diamine and ethane-1,2-diamine-N,N9-diacetic acid. Journal of Inorganic Biochemistry, 91(1), 205-211. [More Information]
• Hambley, T., Hibbs, D., Turner, P., Howard, S., Hursthouse, M. (2002). Insights into bonding and hydrogen bond directionality in thioacetamide from the experimental charge distribution. Journal of the Chemical Society Perkin Transactions 2, 2(2002), 235-239. [More Information]
• Munk, V., Cham, S., Fenton, R., Hocking, R., Hambley, T. (2002). Insights into the van der Waals Radius of Low-Spin Ni(II) from Molecular Mechanics Studies and the Crystal Structures of [Ni(cis-cyclohexane-1,3-diamine)2]Cl2, [Ni{(R)-5,5,7-trimethyl-1,4-diazacycloheptane}2]Cl2.H2O and [Ni(5,7-dimethyl-1,4-diazacyclohept. Australian Journal of Chemistry, 55(8), 523-529. [More Information]
• Field, L., Messerle, B., Soler, L., Hambley, T., Turner, P. (2002). Iron(II) complexes containing poly(1-pyrazolyl)methane ligands. Journal of Organometallic Chemistry, 655(1-2), 146-157. [More Information]
• Greguric, A., Greguric, I., Hambley, T., Aldrich-Wright, J., Collins, J. (2002). Minor groove intercalation of Delta-[Ru(Me2phen)2dppz]2+ to the hexanucleotide d(GTCGAC)2. Dalton Transactions, 10, 849-855. [More Information]
• Hall, M., Hambley, T. (2002). Platinum(IV) antitumour compounds: their bioinorganic chemistry. Coordination Chemistry Reviews, 232(1-2), 49-67. [More Information]
• Cullinane, C., Deacon, G., Drago, P., Hambley, T., Nelson, K., Webster, L. (2002). Preparation and cell growth inhibitory activity of [PtR2L2] (R=polyfluorophenyl, L2 = diene, cyclohexane-1,2-diamine (chxn) or cis-(dimethyl sulfoxide)2) and the X-ray crystal structure of [Pt(C6F5)2(cis-chxn)]. Journal of Inorganic Biochemistry, 89, 293-301. [More Information]
• Hocking, R., Hambley, T. (2002). Statistical and Molecular Mechanics Analysis of the Effects of Changing Donor Type on Bond Length in the Two Series [CoIIINnO6-n] and [NiIINnO6-n] (n = 0-6): A New Route to Bond-Stretch Parameters. Inorganic Chemistry, 41(10), 2660-2666. [More Information]
• Munk, V., Diakos, C., Messerle, B., Fenton, R., Hambley, T. (2002). Stereospecificity and Enantioselectivity in the Binding of the Platinum(II) Complex [PtCl2(tmdz)] (tmdz=5,5,7-Trimethyl-1,4-diazacycloheptane) to Dinucleotides and Oligonucleotides. Chemistry - A European Journal, 8(23), 5486-5493.
• Hall, M., Failes, T., Hibbs, D., Hambley, T. (2002). Structural Investigations of Palladium(II) and Platinum(II) Complexes of Salicylhydroxamic Acid. Inorganic Chemistry, 41(5), 1223-1228. [More Information]
• Dolman, R., Deacon, G., Hambley, T. (2002). Studies of the binding of a series of platinum(IV) complexes to plasma proteins. Journal of Inorganic Biochemistry, 88(3-4), 260-267. [More Information]
• Wei, G., Hambley, T., Lawrance, G., Maeder, M. (2002). Synthesis and Complexation of a Chiral Sexidentate Pendant-Arm Macropolycyclic Polyamino Acid. Australian Journal of Chemistry, 55(10), 667-673. [More Information]
• Battle, A., Platts, J., Hambley, T., Deacon, G. (2002). Synthesis, spectroscopy, and theoretical studies of platinum(II) phosphate complexes. Dalton Transactions, , 1898-1902. [More Information]
• Aldrich-Wright, J., Fenton, R., Greguric, A., Hambley, T., Williams, P. (2002). The stereospecific synthesis of lambda-alpha-{dipyrido[3,2-a:2'3'-c]-(6,7,8,9-tetrahydro)phenazine[N,N'-di(2-picolyl)-2,5-dimethyl-2S,5S-diaminocyclohexane]ruthenium(II)} and related beta-isomers. Dalton Transactions, 24, 4666-4671. [More Information]
• Hambley, T., Katsifis, A., Knott, R., Mattner,, F., Dikic, B. (2002). The Structures of Imidazenil and Iodoimidazenil. Australian Journal of Chemistry, 55(11), 737-739. [More Information]
• Field, L., Hambley, T., Humphrey, P., Masters, A., Turner, P. (2002). X-ray Crystal Structure of (eta5-Pentaphenylcyclopentadienyl){1-(eta5/6-phenyl)-2,3,4,5-tetraphenylcyclopentadienyl}iron(II), [Fe(eta5-C5Ph5){eta5/6-C6H5)C5Ph4}], a Linkage Isomer of Decaphenylferrocene. Inorganic Chemistry, 41(18), 4618-4620. [More Information]

2001

• Hambley, T., Turner, P., Jackson, T., Kojima,, M., Knott,, R., Lambrecht,, R. (2001). 6,6,9,9-tetramethyl-1,2,5,6,9,9a-hexahydro-imidazo[2,1-d][1,2,5]dithiazepin-1-ium triiodide. Acta Crystallographica. Section E: Structure Reports Online, E57, 315-317.
• Hall, B., Hanrahan, J., Johnston, G., Hambley, T., Hibbs, D. (2001). 6-Methylflavone. Acta Crystallographica. Section E: Structure Reports Online, E57.
• Platts, J., Hibbs, D., Hambley, T., Hall, M. (2001). Calculation of the hydrophobicity of platinum drugs. Journal of Medicinal Chemistry, 44(3), 472-474. [More Information]
• Weder, J., Hambley, T., Kennedy, B., Lay, P., Rich, A., Foran, G. (2001). Determination of the structures of antiinflammatory copper(II) dimers of indomethacin by multiple-scattering analyses of X-ray absorption fine structure data. Inorganic Chemistry, 40, 1295-1302.
• Headlam, H., Weeks, C., Turner, P., Hambley, T., Lay, P. (2001). Dinuclear chromium(V) amino acid complexes from the reduction of chromium(VI) in the presence of amino acid ligands: XAFS characterization of a chromium(V) amino acid complex. Inorganic Chemistry, 40, 5097-5105. [More Information]
• Cham, S., Diakos, C., Ellis, L., Fenton, R., Munk, V., Hambley, T., Messerle, B. (2001). Isomer formation in the binding of [PtCl2(cis-cyclohexane-1,3-diamine)] to oligonucleotides and the X-ray crystal structure of [PtCl2(cis-cyclohexane-1,3-diamine)].dimethylformamide. Dalton Transactions, 2001, 2769-2774.
• Hambley, T., Lindoy, L., Reimers, J., Turner, P., Wei, G., Widmer-Cooper, A. (2001). Macrocyclic ligand design. X-ray, DFT and solution studies of the effect of N-methylation and N-benzylation of 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane on its affinity for selected transition and post-transition metal ions. Dalton Transactions, 2001, 614-620. [More Information]
• Hambley, T., Bonin, A., Davies, N., Dillon, C., Weder, J., Kennedy, B., Lay, P., Morgan, Y., Zhou, Q., Biffin, J., et al (2001). Metal complexes of non-steroidal anti-inflammatory drugs: An opportunity yet to be realised. 10th International Conference on Bioinorganic Chemistry, : Ads & Adea.
• Dillon, C., Davies, N., Hambley, T., Kennedy, B., Lay, P., Zhou, Q., Stampfl, A., Cai, Z., Lai, B., Biffin, J., et al (2001). Micro-SRIXE and micro-XANES analysis of carcinogens and anti-inflammatory drugs in mammalian cells. 10th International Conference on Bioinorganic Chemistry, : Ads & Adea.
• Hambley, T., Jones, A. (2001). Molecular mechanics modelling of Pt/nucleotide and Pt/DNA interactions. Coordination Chemistry Reviews, 212, 35-59. [More Information]
• Hambley, T., Comba, P. (2001). Molecular Modeling of Inorganic Compounds. Germany: Wiley - V C H Verlag GmbH & Co. KGaA.
• Wong, P., Davies, M., Hambley, T. (2001). Oxidation of [PtIICl2(ethane-1,2-diamine-N,N'dicarboxylic Acid)] and Ligand Ring Closure in the Platinum(IV) Oxidation State. Australian Journal of Chemistry, 54, 303-306. [More Information]
• Hambley, T. (2001). Platinum binding to DNA: Structural controls and consequences. Dalton Transactions, 2001, 2711-2718.
• Field, L., Soler, L., Buys, I., Hambley, T., Messerle, B. (2001). Polypyrazolylmethane complexes of ruthenium. Dalton Transactions, 2001, 1959-1965.
• Morgan, Y., Turner, P., Kennedy, B., Hambley, T., Lay, P., Biffin, J., Regtop, H., Warwick, B. (2001). Preparation and characterization of dinuclear copper-indomethacin anti-inflammatory drugs. Inorganica Chimica Acta, 324, 150-161. [More Information]
• Hall, M., Dillon, C., Hambley, T., Davies, M., Price, A. (2001). Reactions and reduction of platinum(IV) anticancer complexes. 10th International Conference on Bioinorganic Chemistry, : Ads & Adea.
• Hambley, T., Ling, E., Munk, V., Davies, M. (2001). Steric control of stereoselective interactions between the platinum(II) complex [PtCl2(1,4-diazacycloheptane)] and DNA: Comparison with cis-[PtCl2(NH3)2] and [PtCl2(ethane-1,2-diamine)] using DNA binding and molecular modeling studies. Journal of Biological Inorganic Chemistry, 6(5-6), 534-542.
• Hambley, T., Habtemariam,, A., Parkinson, J., Margiotta, N., Parsons, S., Sadler, P. (2001). Structure and dynamics of a platinum(II) aminophosphine complex and its nucleobase adducts. Dalton Transactions, 2001, 362-372. [More Information]
• Davies, M., Diakos, C., Messerle, B., Hambley, T. (2001). Structure, stability, and interconversion barriers of the rotamers of cis-[PtIICl2(quinoline)2] and cis-[[PtIICl2(3-bromoquinoline)(quinoline)] from X-ray crystallography, NMR spectroscopy and molecular mechanics evidence. Inorganic Chemistry, 40, 3048-3054.
• Giannikopoulos, G., Carter, J., Fenton, R., Hambley, T. (2001). The synthesis of ethane-1,2-diamine-N,N'-bis(methylenephosphonic) acid and its platinum(II) complex, Bis{ethane-1,2-diamine-N,N'-bis(methylenephosphonato)}platinum(II). Australian Journal of Chemistry, 54, 127-130.
• Liu, X., Kassiou, M., Christie, M., Hambley, T. (2001). Trishomocubanes: requirements for sigma receptor binding and subtype selectivity. Australian Journal of Chemistry, 54, 31-36.
• Burns, C., Field, L., Hambley, T., Lin, T., Ridley, D., Turner, P., Wilkinson, M. (2001). X-ray crystal structural determination of copper(II)-nitrilotriacetic acid-Bis(N-methylimidazol-2-yl)ketone ternary complex. ARKIVOC, vii, 157-165.

2000

• Codd, R., Levina, A., Zhang, L., Hambley, T., Lay, P. (2000). Characterization and X-ray absorption spectroscopic studies of bis[quinato(2)]oxochromate(V). Inorganic Chemistry, 39(5), 990-997.

1999

• Field, L., Messerle, B., Smernik, R., Hambley, T., Turner, P. (1999). Butenynyl complexes of iron(II) containing the tripodal tetraphosphine ligand P(CH2CH2PMe2)3. Dalton Transactions, (15), 2557-2562. [More Information]
• Elgafi, S., Field, L., Messerle, B., Turner, P., Hambley, T. (1999). Rhodium complexes containing bidentate imidazolyl ligands: Synthesis and structure. Journal of Organometallic Chemistry, 588(1), 69-77. [More Information]

1997

• Field, L., Messerle, B., Smernik, R., Hambley, T., Turner, P. (1997). Iron Complexes Containing the Tripodal Tetraphosphine Ligand P(CH2CH2PMe2)3. Inorganic Chemistry, 36(13), 2884-2892. [More Information]
• Elgafi, S., Field, L., Messerle, B., Buys, I., Hambley, T. (1997). Trisimidazole complexes of ruthenium and osmium. Journal of Organometallic Chemistry, 538, 119-128. [More Information]

1996

• Hambley, T., Ling, E., Messerle, B. (1996). Combined NMR and Molecular Mechanics Study of the Isomers Formed in the Reaction of Dichloro(1,4-diazacycloheptane)platinum(II) with the Dinucleotide d(GpG). Inorganic Chemistry, 35(16), 4663-4668. [More Information]

1994

• Buys, I., Elgafi, S., Field, L., Hambley, T., Messerle, B. (1994). Formation of a Novel Dipyrrolopyrrole Mediated by a 1,4-Diaza-1,3-diene Complex of Iron. Inorganic Chemistry, 33(7), 1539-1542. [More Information]